These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of radiation therapy in non-small cell lung cancer. Mohiuddin MM; Choi NC Semin Respir Crit Care Med; 2005 Jun; 26(3):278-88. PubMed ID: 16052429 [TBL] [Abstract][Full Text] [Related]
23. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601 [TBL] [Abstract][Full Text] [Related]
24. Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer. Wagner H J Clin Oncol; 2008 Aug; 26(24):3920-2. PubMed ID: 18711179 [No Abstract] [Full Text] [Related]
25. An accelerated radiotherapy scheme using a concomitant boost technique for the treatment of unresectable stage III non-small cell lung cancer. Izmirli M; Yaman F; Buyukpolat MY; Yoney A; Unsal M Jpn J Clin Oncol; 2005 May; 35(5):239-44. PubMed ID: 15886271 [TBL] [Abstract][Full Text] [Related]
27. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230 [TBL] [Abstract][Full Text] [Related]
28. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412 [TBL] [Abstract][Full Text] [Related]
29. Comments on A case of radiation myelopathy after 2 x 8.5 Gy for inoperable non-small cell lung cancer, Dardoufas et al., European Journal of Cancer, 31A, Nos 13/14, pp. 2418-2419, 1995. Macbeth F Eur J Cancer; 1996 Aug; 32A(9):1616-7. PubMed ID: 8911129 [No Abstract] [Full Text] [Related]
30. Comments on A case of radiation myelopathy after 2 x 8.5 Gy for inoperable non-small cell lung cancer, Dardoufas et al., European Journal of Cancer, 31A, Nos 13/14, pp.2418-2419, 1995. Hocking M Eur J Cancer; 1996 Aug; 32A(9):1616. PubMed ID: 8911128 [No Abstract] [Full Text] [Related]
31. Tumor motion control in the treatment of non small cell lung cancer. Rosenzweig KE; Yorke E; Amols H; Mageras GS; Giraud P; Katz MS; Leibel SA Cancer Invest; 2005; 23(2):129-33. PubMed ID: 15813505 [TBL] [Abstract][Full Text] [Related]
32. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233 [TBL] [Abstract][Full Text] [Related]
33. Progressive myelopathy due to radiation. Coy P; Baker S; Dolman CL Can Med Assoc J; 1969 Jun; 100(24):1129-33. PubMed ID: 5786006 [No Abstract] [Full Text] [Related]
34. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382 [TBL] [Abstract][Full Text] [Related]
35. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271 [TBL] [Abstract][Full Text] [Related]
36. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Piotrowski T; Matecka-Nowak M; Milecki P Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]. El Sharouni SY; Aerts JG; Senan S; De Ruysscher DK; Groen HJ; Paul MA; Smit EF; Vonk EJ; Verhagen AF; Schramel FM Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2714-7. PubMed ID: 19192584 [TBL] [Abstract][Full Text] [Related]